REG - Inspiration Health - Director/PDMR Shareholding

Inspiration HealthcareAnnouncement

12/03/2025 18:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250312:nRSL4497Aa&default-theme=true

RNS Number : 4497A  Inspiration Healthcare Group PLC  12 March 2025

Inspiration Healthcare Group plc

("Inspiration Healthcare" or the "Company" )

 

PDMR Dealing

 

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology
company, announces that it has been notified that Neil Campbell, a
Non-executive Director of Inspiration Healthcare, has sold 2,000,000 ordinary
shares of 10 pence each in the Company ("Ordinary Shares") at a price set out
in the form below.

 

Following the sale, Neil Campbell holds a total of 2,216,646 Ordinary Shares,
representing approximately 2.5 per cent. of the Company's issued ordinary
share capital.

 

Neil Campbell has confirmed that he does not currently intend to sell any
further Ordinary Shares.

 

This announcement, including the notification below, is made in accordance
with the requirements of the UK Market Abuse Regulation.

 

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING
MANAGERIAL RESPONSIBILITIES

 1    Details of the person discharging managerial responsibilities / person closely

    associated

 a)   Name

                                                                    Neil Campbell

 2    Reason for the notification

 a)   Position/status                                              PDMR - Non-Executive Director

 b)   Initial notification /Amendment                              Initial Notification

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         Inspiration Healthcare Group Plc

 b)   LEI                                                          213800GKFT3ENAPMDL15

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted

 a)   Description of the financial instrument, type of instrument  Ordinary Shares of 10 pence each

      Identification code                                          ISIN: GB00BXDZL105

 b)   Nature of the transaction                                    Sale of Ordninary Shares

 c)   Price(s) and volume(s)

                                                                                     Price(s)          Volume(s)
                                                                                     16.5 pence        2,000,000

 d)   Aggregated information

      - Aggregated volume                                          N/A

      - Price

 e)   Date of the transaction                                      12.03.2025

 f)   Place of the transaction                                     Off Market

 

For further information, please contact:

 

 Inspiration Healthcare Group plc                                                  Tel: +44 (0)330
                                                   175 0000
 Roy Davis, Non-Executive Chair

 Raffi Stepanian, Chief Executive Officer

 Alan Olby, Chief Financial Officer

 Panmure Liberum (Nominated Adviser & Broker)                                      Tel: +44 (0)20
                                                   3100 2000
 Richard Lindley

 Will Goode

 Emma Earl

 Will King

 Walbrook PR Ltd (Media & IR)                      Tel: +44 (0)20 7933 8780 or

                                                   inspirationhealthcare@walbrookpr.com
 Anna Dunphy                                       Mob: +44 (0) 7876 741 001
 Louis Ashe-Jepson                                 Mob: +44 (0) 7747 515 393

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHFLFEDVIIFLIE